| Primary |
| Product Used For Unknown Indication |
100.0% |
|
|
| Secondary |
| Product Used For Unknown Indication |
24.0% |
| Atrial Fibrillation |
15.8% |
| Arrhythmia |
15.1% |
| Drug Use For Unknown Indication |
14.4% |
| Hypertension |
5.5% |
| Pulmonary Arterial Hypertension |
3.4% |
| General Anaesthesia |
2.7% |
| Type 2 Diabetes Mellitus |
2.7% |
| Dyslipidaemia |
2.1% |
| Liver Disorder |
2.1% |
| Major Depression |
2.1% |
| Parkinson's Disease |
2.1% |
| Depression |
1.4% |
| Poisoning Deliberate |
1.4% |
| Sleep Disorder |
1.4% |
| Thrombosis Prophylaxis |
1.4% |
| Product Used For Unknown Indication |
0.7% |
| Antibiotic Prophylaxis |
0.7% |
| Arteritis |
0.7% |
| Asthma |
0.7% |
|
| Renal Failure Acute |
12.8% |
| Interstitial Lung Disease |
10.3% |
| Vomiting |
10.3% |
| Cytolytic Hepatitis |
5.1% |
| Essential Tremor |
5.1% |
| Liver Injury |
5.1% |
| Orthostatic Hypotension |
5.1% |
| Pallor |
5.1% |
| Syncope |
5.1% |
| Transient Ischaemic Attack |
5.1% |
| Vagus Nerve Disorder |
5.1% |
| Viral Infection |
5.1% |
| Balance Disorder |
2.6% |
| Bradycardia |
2.6% |
| Cardiac Disorder |
2.6% |
| Fall |
2.6% |
| Hypersomnia |
2.6% |
| Hyperthyroidism |
2.6% |
| Hypotension |
2.6% |
| Intentional Overdose |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
35.5% |
| Atrial Fibrillation |
12.9% |
| Hypertension |
9.5% |
| Drug Use For Unknown Indication |
6.9% |
| Arrhythmia |
5.0% |
| Prophylaxis |
3.6% |
| Rheumatoid Arthritis |
3.6% |
| Essential Thrombocythaemia |
2.9% |
| Breast Cancer |
2.0% |
| Depression |
1.9% |
| Cerebrovascular Accident Prophylaxis |
1.7% |
| Lung Disorder |
1.7% |
| Premedication |
1.7% |
| Thrombosis Prophylaxis |
1.7% |
| Type 2 Diabetes Mellitus |
1.7% |
| Mantle Cell Lymphoma |
1.6% |
| Parkinson's Disease |
1.6% |
| Chronic Lymphocytic Leukaemia |
1.4% |
| Diabetes Mellitus |
1.4% |
| Osteoporosis |
1.4% |
|
| Renal Failure Acute |
15.2% |
| Thrombocytopenia |
6.5% |
| Lung Disorder |
5.4% |
| Overdose |
5.4% |
| Death |
4.3% |
| Drug Interaction |
4.3% |
| Fall |
4.3% |
| Haematuria |
4.3% |
| Hallucination |
4.3% |
| International Normalised Ratio Increased |
4.3% |
| Ischaemic Stroke |
4.3% |
| Nausea |
4.3% |
| Renal Failure |
4.3% |
| Toxic Skin Eruption |
4.3% |
| Transient Ischaemic Attack |
4.3% |
| Urinary Tract Infection |
4.3% |
| Vomiting |
4.3% |
| Weight Decreased |
4.3% |
| Confusional State |
3.3% |
| Hepatitis |
3.3% |
|
| Interacting |
| Atrial Fibrillation |
28.6% |
| Bronchitis |
28.6% |
| Prostatitis |
14.3% |
| Pyelonephritis Acute |
14.3% |
| Urinary Tract Infection |
14.3% |
|
| Vision Blurred |
66.7% |
| Inappropriate Antidiuretic Hormone Secretion |
33.3% |
|
